Zinc oxide nanoparticles modulate the gene expression of ZnT1 and ZIP8 to manipulate zinc homeostasis and stress-induced cytotoxicity in human neuroblastoma SH-SY5Y cells

Chien-Yuan Pan,Fang-Yu Lin,Lung-Sen Kao,Chien-Chang Huang,Pei-Shan Liu
DOI: https://doi.org/10.1371/journal.pone.0232729
IF: 3.7
2020-09-11
PLoS ONE
Abstract:Zinc ions (Zn2+) are important messenger molecules involved in various physiological functions. To maintain the homeostasis of cytosolic Zn2+ concentration ([Zn2+]c), Zrt/Irt-related proteins (ZIPs) and Zn2+ transporters (ZnTs) are the two families of proteins responsible for decreasing and increasing the [Zn2+]c, respectively, by fluxing Zn2+ across the membranes of the cell and intracellular compartments in opposite directions. Most studies focus on the cytotoxicity incurred by a high concentration of [Zn2+]c and less investigate the [Zn2+]c at physiological levels. Zinc oxide-nanoparticle (ZnO-NP) is blood brain barrier-permeable and elevates the [Zn2+]c to different levels according to the concentrations of ZnO-NP applied. In this study, we mildly elevated the [Zn2+]c by ZnO-NP at concentrations below 1 μg/ml, which had little cytotoxicity, in cultured human neuroblastoma SH-SY5Y cells and characterized the importance of Zn2+ transporters in 6-hydroxy dopamine (6-OHDA)-induced cell death. The results show that ZnO-NP at low concentrations elevated the [Zn2+]c transiently in 6 hr, then declined gradually to a basal level in 24 hr. Knocking down the expression levels of ZnT1 (located mostly at the plasma membrane) and ZIP8 (present in endosomes and lysosomes) increased and decreased the ZnO-NP-induced elevation of [Zn2+]c, respectively. ZnO-NP treatment reduced the basal levels of reactive oxygen species and Bax/Bcl-2 mRNA ratios; in addition, ZnO-NP decreased the 6-OHDA-induced ROS production, p53 expression, and cell death. These results show that ZnO-NP-induced mild elevation in [Zn2+]c activates beneficial effects in reducing the 6-OHDA-induced cytotoxic effects. Therefore, brain-delivery of ZnO-NP can be regarded as a potential therapy for neurodegenerative diseases.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the intracellular homeostasis regulation of zinc ions (Zn²⁺) and its impact on neurodegenerative diseases. Specifically, the study focused on how zinc oxide nanoparticles (ZnO - NP) affect the intracellular zinc ion concentration ([Zn²⁺]c) by regulating the gene expression of zinc transporters ZnT1 and ZIP8, and then regulate the cell's response to oxidative stress and cytotoxicity. The main objectives of the study include: 1. **Explore the impact of ZnO - NP on the intracellular zinc ion concentration**: - The study found that low - dose ZnO - NP can transiently increase the intracellular zinc ion concentration, and this increase gradually returns to the baseline level within 24 hours. 2. **Analyze the expression changes of ZnT1 and ZIP8 under the action of ZnO - NP**: - After ZnO - NP treatment, the expression of ZnT1 increased significantly, and the expression of ZIP8 also increased at low doses, but decreased at high doses. This indicates that ZnT1 and ZIP8 play a crucial role in regulating the intracellular zinc ion concentration. 3. **Evaluate the impact of ZnO - NP on cytotoxicity**: - Low - dose ZnO - NP can reduce the basal level of reactive oxygen species (ROS) and the Bax/Bcl - 2 mRNA ratio, thereby reducing the risk of apoptosis. In addition, ZnO - NP can also alleviate the ROS generation and cell death caused by 6 - hydroxydopamine (6 - OHDA). 4. **Explore the possibility of ZnO - NP as a potential treatment for neurodegenerative diseases**: - The research results show that by regulating the intracellular zinc ion concentration, ZnO - NP may have the ability to protect nerve cells from oxidative stress damage, and thus is expected to become a new strategy for the treatment of neurodegenerative diseases. In summary, this paper mainly explores that ZnO - NP affects the intracellular zinc ion concentration by regulating the expression of zinc transporters, and then resists oxidative stress and cytotoxicity, ultimately providing new ideas for the treatment of neurodegenerative diseases.